|
Market Closed -
Other stock markets
|
After market 20:59:40 | |||
| 154.8 EUR | -0.51% |
|
154.8 | +0.02% |
| 06-27 | Chemicals collective agreement: Bonus days for union members | DP |
| 06-27 | Chemicals collective bargaining agreement: extra day for trade unionists | DP |
FRANKFURT (Reuters) - Shares in Germany's Merck KGaA slumped 8.9% at the open on Tuesday after the diversified group late on Monday said a trial testing a head and neck cancer drug, previously seen as promising, would be stopped for lack of efficacy.
(Reporting by Ludwig Burger; Editing by Miranda Murray)
| 1st Jan change | Capi. | |
|---|---|---|
| +7.39% | 72.4B | |
| +15.93% | 8.98B | |
| +17.59% | 4.28B | |
| -22.81% | 4.28B | |
| +25.93% | 4.01B | |
| +4.64% | 2.16B | |
| +9.09% | 1.95B | |
| -36.86% | 1.9B | |
| -0.50% | 1.64B | |
| -48.24% | 1.63B |
MERCK KGAA 
